The Valley Desk

NCT00307125 · Interventional trial

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Overall registry status Completed

Phase 2

Conditions Graft Function/Survival, Kidney Transplant, Kidney Transplant Recipient, de Novo HLA Antibodies Development

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov